Clinical Trials on Glutamate Receptor
Total 600 results
-
National Institute of Mental Health (NIMH)CompletedHealthy | PET Scan | Glutamate Receptor | mGlur5 Protein | Excitatory Amino Acid Receptors | Drug KineticsUnited States
-
University Hospital Inselspital, BerneUniversity of Zurich; University Hospital MuensterCompletedPolymorphism, Genetic | Libido | Receptors, Androgen | Androgen EffectSwitzerland
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedEvaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic PatientsItaly
-
University of SurreyFrieslandCampinaRecruitingAnxiety | Gamma-Aminobutyric Acid | Glutamate | Emotion Regulation AbilitiesUnited Kingdom
-
Medical Centre LeeuwardenWithdrawnMechanical Ventilation | Length of Stay | Glutamine
-
Medical Centre LeeuwardenCompletedGlutamine LevelsNetherlands
-
Tianjin Medical University Second HospitalRecruitingSolid Tumor | FGF Receptor Gene Mutation | FGF Amplification | FGF Receptor Gene Family Rearrangement | FGF Receptor Gene TranslocationChina
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedEstrogen Receptor Positive Breast Cancer | Androgen Receptor Gene Overexpression | Progesterone Receptor Positive Tumor | Metastatic Breastcancer | Estrogen Receptor Negative Neoplasm | Progesterone Receptor Negative NeoplasmItaly
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.; Translational Breast Cancer... and other collaboratorsTerminatedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
St Vincent's Hospital, SydneyTerminatedSolid Tumor | Androgen Receptor Gene OverexpressionAustralia
-
Colorado State UniversityCompletedReceptor BlockadeUnited States
-
Yale UniversityJanssen Scientific Affairs, LLCNot yet recruitingMuscarinic Receptor OccupancyUnited States
-
Assistance Publique - Hôpitaux de ParisNational Research Agency, FranceRecruitingDiabetic | Cardiovascular Complications | GlutamineFrance
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor PositiveUnited States
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Not yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
Aristotle University Of ThessalonikiCompletedPoor Ovarian Response | Androgen Receptor Gene Overexpression | Normal Responders | Bologna Criteria
-
National Institute of Mental Health (NIMH)CompletedBaseline | Blocking Receptor BindingUnited States
-
Toshihiko KonoUnknown
-
Catharina Ziekenhuis EindhovenErasmus Medical Center; Tilburg University; Stichting PAMM; Eindhoven University...CompletedThyrothrophin Receptor in Myometrium TissueNetherlands
-
Infertility Treatment Center DortmundWeill Medical College of Cornell UniversityCompletedIVF | Subfertility | Estradiol Receptor Polymorphism | Progesterone Receptor PolymorphismGermany
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of CatanzaroUnknownAndrogen Receptor Abnormal | Insulin-Like Growth Factor I Deficiency | Insulin Receptor, Defect inItaly
-
West China HospitalRecruitingProbiotics | Gut Microbiota | Bifidobacterium | Radiation Proctitis | GlutamineChina
-
University of PennsylvaniaActive, not recruitingHealthy Volunteer | D3 Dopamine Receptor | Cocaine-dependentUnited States
-
National Institute of Nursing Research (NINR)Not yet recruitingRyanodine Receptor 1-Related Myopathy | Ryanodine Receptor 1 Related DisordersUnited States
-
Seoul National University HospitalCompletedCognition | Antipsychotics | Brain Metabolism | Dopamine Receptor OccupancyKorea, Republic of
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedBreast Carcinoma | Estrogen Receptor Negative | Progesterone Receptor NegativeUnited States, Guam
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
Assiut UniversityNot yet recruitingThrombopoietin Receptor Agonist
-
Rhythm Pharmaceuticals, Inc.CompletedLeptin Receptor Deficiency ObesityNetherlands, Germany, United Kingdom, Canada, France, Réunion
-
National Institute of Mental Health (NIMH)CompletedmGluR5 ReceptorsUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
University of California, Los AngelesTerminatedCognitive Function | Methamphetamine Abuse | Dopamine D2/3 Receptor AvailabilityUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Instituto BernabeuNot yet recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.Active, not recruitingSalivary CancerUnited States
-
AstraZenecaCompleted
-
AC Camargo Cancer CenterH. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingNeuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive TumorUnited States, Brazil
-
National Cancer Institute (NCI)TerminatedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Yale UniversityVA Office of Research and DevelopmentCompletedNMDA Receptor FunctionUnited States
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
University of Eastern FinlandCompletedVitamin D Receptor Target Gene Expression | Serum 25(OH)D ConcentrationFinland
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del FarmacoUnknownMetastatic Breast Cancer | Hormone Receptor Positive Breast Cancer | Hormone Receptor Negative Breast CancerItaly
-
Bispebjerg HospitalInstitute of Sports Medicine, CopenhagenCompletedMuscle Strength | Tendon Elasticity | Muscle CSA | Tendon CSA | VDR ReceptorDenmark
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompletedantimüllerian Hormone and Gonadotrophin Receptor Polymorphism as Predictors of Ovarian ResponseSpain
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
The Netherlands Cancer InstituteAstellas Pharma IncCompletedProstate Cancer | Androgen Receptor Abnormal | DNA